Article
Targeting of TGFβ signature and its essential component CTGF by miR-18 correlates with improved survival in glioblastoma.
RNA (New York, N.Y.) - 1 Feb 2013
Fox Jamie L, Dews Michael, Minn Andy J, Thomas-Tikhonenko Andrei
Abstract excerpt
The miR-17∼92 cluster is thought to be an oncogene, yet its expression is low in glioblastoma multiforme (GBM) cell lines. This could allow unfettered expression of miR-17∼92 target genes such as connective tissue growth factor (CTGF; or CCN2), which is known to contribute to GBM pathogenesis. Indeed, microRNA-18a (but not other miR-17∼92 members) has a functional site in the CTGF 3' UTR, and its forced...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
